Opioid modulation of resting-state anterior cingulate cortex functional connectivity.
Stephanie M Gorka1, Daniel A Fitzgerald2, Harriet de Wit3
1Department of Psychiatry, University of Illinois-Chicago, Chicago, IL, USA Department of Psychology, University of Illinois-Chicago, Chicago, IL, USA sgorka2@uic.edu.
Journal of Psychopharmacology (Oxford, England)
|September 20, 2014
Summary
Oxycodone disrupts brain connectivity, potentially explaining its pain relief. This study found reduced functional coupling in key brain regions associated with pain processing after oxycodone administration.
Area of Science:
- Neuroscience
- Pharmacology
- Medical Imaging
Background:
- Opioid analgesics like oxycodone are misused for self-medicating physical and emotional pain.
- The brain's 'pain matrix,' including the insula and anterior cingulate cortex (ACC), is implicated in pain processing.
- Understanding oxycodone's neural mechanisms is crucial for addressing its misuse.
Purpose of the Study:
- To investigate the effects of oxycodone on resting-state functional connectivity within the brain's pain network.
- To examine how different doses of oxycodone impact functional coupling between the ACC and other pain matrix regions.
Main Methods:
- Utilized functional magnetic resonance imaging (fMRI) in a within-subjects, randomized, double-blind, placebo-controlled, dose-response design.
- 14 healthy subjects underwent resting-state scans after receiving placebo, 10 mg, or 20 mg of oxycodone.
- Analyzed functional correlations between dorsal and rostral ACC seed regions and the pain matrix.
Main Results:
- Both oxycodone doses significantly reduced functional coupling between the dorsal ACC and the anterior insula/putamen compared to placebo.
- Oxycodone also decreased functional coupling between the rostral ACC and the right insula.
- No significant dose-dependent differences were observed between the 10 mg and 20 mg oxycodone conditions.
Conclusions:
- Oxycodone may exert its analgesic effects by disrupting functional connectivity within the ACC-insula and ACC-putamen pathways.
- These preliminary findings suggest a potential neural basis for oxycodone's impact on both physical and emotional pain processing.
- Further research is needed to confirm these findings, as they did not withstand correction for multiple comparisons.
More Related Videos
Related Concept Videos
Opioid Receptors: Overview
7.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.0K
Analgesia and Pain Management
3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K


